Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
14,500
Employees14,500
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
14,500
Employees14,500

ZTS Key Statistics

Market cap
32.25B
Market cap32.25B
Price-Earnings ratio
13.21
Price-Earnings ratio13.21
Dividend yield
2.58%
Dividend yield2.58%
Average volume
13.55M
Average volume13.55M
High today
$79.95
High today$79.95
Low today
$76.49
Low today$76.49
Open price
$78.34
Open price$78.34
Volume
654.66K
Volume654.66K
52 Week high
$172.23
52 Week high$172.23
52 Week low
$72.38
52 Week low$72.38

Stock Snapshot

Zoetis(ZTS) stock is priced at $76.93, giving the company a market capitalization of 32.25B. It carries a P/E multiple of 13.21 and pays a dividend yield of 2.6%.

On 2026-05-21, Zoetis(ZTS) stock traded between a low of $76.49 and a high of $79.95. Shares are currently priced at $76.93, which is +0.6% above the low and -3.8% below the high.

The Zoetis(ZTS)'s current trading volume is 654.66K, compared to an average daily volume of 13.55M.

During the past year, Zoetis(ZTS) stock moved between $72.38 at its lowest and $172.23 at its peak.

During the past year, Zoetis(ZTS) stock moved between $72.38 at its lowest and $172.23 at its peak.

ZTS News

Simply Wall St 3h
Zoetis Faces Fraud Probe As Burry Backs Dividend-Paying Animal Health Firm

A securities law firm has launched an investigation into Zoetis (NYSE:ZTS) over potential securities fraud tied to its revised 2026 outlook. The probe follows...

Zoetis Faces Fraud Probe As Burry Backs Dividend-Paying Animal Health Firm
TipRanks 16h
Zoetis Declares Third-Quarter 2026 Cash Dividend

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, person...

Nasdaq 3d
Monday 5/18 Insider Buying Report: ADC, ZTS

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably...

Monday 5/18 Insider Buying Report: ADC, ZTS

Analyst ratings

64%

of 22 ratings
Buy
63.6%
Hold
36.4%
Sell
0%

More ZTS News

TipRanks 3d
Zoetis price target lowered to $112 from $145 at Citi

Citi lowered the firm’s price target on Zoetis (ZTS) to $112 from $145 and keeps a Buy rating on the shares. The firm cut the company’s estimates following the...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.